November 20th 2024
Melt Pharmaceuticals announced positive results from its Phase 3 study of MELT-300, a non-IV, non-opioid tablet for procedural sedation during cataract surgery. The results support a regulatory submission, with potential to revolutionize sedation practices in various medical specialties.
AI-related innovations for laser cataract technology mark a milestone in history of device
October 30th 2024The integration of artificial intelligence in laser cataract technology is shifting the paradigm for the future of cataract surgery and is driving increased precision and improved outcomes for patients.
Read More
AAO 2024: Centricity Vision to unveil new ZEPTOLink enhancements for improved efficiency and control
October 15th 2024Centricity Vision announced new ZEPTOLink enhancements, reducing treatment time by up to 60%. These updates, aimed at improving cataract surgery efficiency and control, will be showcased at the 2024 American Academy of Ophthalmology Annual Meeting in Chicago.
Read More
Study examines efficacy of compound electrolyte intraocular irrigating solution
July 27th 2024A team of researchers in China examined the difference and relationship between optical coherence tomography and optical quality analysis system parameters induced by compound electrolyte intraocular irrigating solution or Ringer lactate solution during uncomplicated cataract surgery.
Read More
New World Medical receives 510k clearance for device for reduction of IOP in patients with POAG
May 22nd 2024The company’s KDB GLIDE is indicated for the excision of trabecular meshwork tissue to reduce intraocular pressure in adult patients with primary open-angle glaucoma during cataract surgery or as a stand-alone procedure.
Read More